Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT06881836

Public ClinicalTrials.gov record NCT06881836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, 26-week, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of ONO-2020 in Patients With Mild to Moderate Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess safety, tolerability, pharmacokinetics, and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether administering ONO-2020, an epigenetic regulator, may improve cognitive functions like memory and cognition in individuals with Alzheimer's disease dementia.

Study identification

NCT ID
NCT06881836
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ono Pharmaceutical Co., Ltd.
Industry
Enrollment
260 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 24, 2025 (Actual)
Primary completion
Jul 31, 2026 (Actual)
Completion
Sep 1, 2026 (Actual)
Last update posted
Oct 22, 2026

2025 – 2026

United States locations

U.S. sites
60
U.S. states
22
U.S. cities
56
Facility City State ZIP Site status
Banner Alzheimer's Institute (BAI) Phoenix Arizona 85006 —
Clinical Endpoints Scottsdale Arizona 85258 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
Center for Neurosciences-Research Tucson Arizona 85718 —
Profound Research LLC at The Neurology Center of Southern California Carlsbad California 92011 —
Neurology Center of North Orange County Fullerton California 92835 —
Stanford University Palo Alto California 94304 —
Sunwise Clinical Research Walnut Creek California 94596 —
CenExel Rocky Mountain Clinical Research Englewood Colorado 80113 —
Brain Matters Research Delray Beach Florida 33445 —
Quantum Clinical Trials Miami Beach Florida 33140 —
Suncoast Clinical Research New Port Richey Florida 34652 —
Renstar Medical Research Ocala Florida 34470 —
Charter Research - Orlando Orlando Florida 32803 —
Accel Research Sites - Brain and Spine Institute Port Orange Florida 32127 —
USF Health Byrd Alzheimer's Institute Tampa Florida 33613 —
ForCare Clinical Research Tampa Florida 33647 —
Charter Research - The Villages The Villages Florida 32162 —
Conquest Research LLC Winter Park Florida 32789 —
Sandhill Research, LLC d/b/a Accel Research Sites - NeuroStudies CRU Decatur Georgia 30030 —
CenExel iResearch, LLC Savannah Georgia 31405 —
Velocity Clinical Research, Boise Meridian Idaho 83642 —
Re:Cognition Health-Chicago Chicago Illinois 60611 —
Ascension Alexian Brothers Medical Center Elk Grove Village Illinois 60007 —
University of Kansas Medical Center Fairway Kansas 66205 —
Univ of Kentucky Sanders-Brown Center on Aging Lexington Kentucky 40504 —
Boston Clinical Trials Boston Massachusetts 02131 —
ActivMed Research Methuen Massachusetts 01844 —
Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada 89106 —
Vector Clinical Trials Las Vegas Nevada 89128 —
The Cognitive and Research Center of New Jersey Springfield New Jersey 07081 —
Advanced Memory Research Institute of NJ (CenExel AMRI) Toms River New Jersey 08755 —
Advanced Clinical Institute Inc. West Long Branch New Jersey 07764 —
University at Buffalo Buffalo New York 14203 —
The Feinstein Institutes for Medical Research Manhasset New York 11030 —
NYU Center for Cognitive Neurology New York New York 10016 —
AD-CARE; University of Rochester Rochester New York 14620 —
Stony Brook University Hospital Stony Brook New York 11794 —
New Hope Clinical Research Charlotte North Carolina 28211 —
Velocity Clinical Research at Raleigh Neurology Raleigh North Carolina 27607 —
NeuroScience Research Center Canton Ohio 44718 —
University of Cincinnati Cincinnati Ohio 45219 —
Cleveland Clinic Cleveland Ohio 44195 —
The Ohio State University Columbus Ohio 43221 —
Neurology Diagnostics Research Dayton Ohio 45459 —
Neuro Behavioral Clinical Research, Inc. North Canton Ohio 44720 —
Neural Net Research / Center for Cognitive Health Portland Oregon 97225 —
Oregon Health & Science University Portland Oregon 97239 —
Penn Medicine Philadelphia Pennsylvania 19104 —
Rhode Island Hospital Providence Rhode Island 02903 —
Neurology Clinic, P.C. Cordova Tennessee 38018 —
Vanderbilt UMC-Cognitive Med Nashville Tennessee 37212 —
Horizon Clinical Research Group Cypress Texas 77429 —
Texas Neurology Dallas Texas 75206 —
Olympus Clinical Research - Katy Katy Texas 77450 —
Be Well Clinical Studies Round Rock Texas 78681 —
Central Texas Neurology Consultants Round Rock Texas 78681 —
Grayline Research Center Wichita Falls Texas 76309 —
Re:Cognition Health - Fairfax Fairfax Virginia 22031 —
Kingfisher Cooperative; LLC Spokane Washington 99201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06881836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06881836 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →